Biotech Startups

Triplebar builds an AI platform for Genomic Design Automation (GDA), using microfluidics to generate large-scale biological datasets with matched genotype and phenotype at lower cost and faster than liquid handling robotics. It applies machine learning to biological data to support biotechnology research and product engineering.

3 investors

Triumvira is a clinical-stage immuno-oncology company developing autologous and allogeneic T cell therapeutics for cancer treatment. The company applies T cell biology and targeted immunotherapy approaches to address oncology.

3 investors

Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications. The company works on novel gene network therapies for challenging diseases.

3 investors

Tyra is developing oral dabogratinib, a small-molecule therapy being evaluated in clinical studies for skeletal dysplasia and urologic cancers. The company operates in the biotech/pharmaceutical drug development space.

3 investors

uFraction8 develops microfluidics-based filtration systems for bioprocessing applications, enabling energy-efficient harvesting and processing of microbial cell cultures for biopharmaceutical manufacturers. The technology targets industrial-scale bio-manufacturing and is positioned to replace conventional filters and centrifuges in cell culture processing.

3 investors

uLab Systems builds digital orthodontics tools, including software (uDesign, uAssist) and uSmile clear aligners manufactured in the USA, for dental professionals and orthodontic practices. The company offers a platform for personalized orthodontic care aimed at improving treatment outcomes and practice efficiency.

3 investors

Umoja Biopharma develops in vivo CAR T cell cancer therapies using its VivoVec platform, which generates chimeric antigen receptor T cells directly inside a patient's body rather than through the traditional ex vivo process. The company operates its own in-house manufacturing to supply its therapeutics.

3 investors

Uncaged Innovations is a biomaterials company that makes grain- and plant-based leather alternatives using its proprietary BioFuze platform, which replicates the collagen structure of animal leather. Its Elevate material is a tanning-free, scalable leather substitute aimed at industries seeking sustainable, luxury-quality materials.

3 investors

Unchained Labs builds instruments for lipid nanoparticle and other nanomedicine production, spanning R&D formulation screening through GMP-compliant clinical manufacturing. Its Sunny Suite uses a consistent mixing process to help pharmaceutical and biotech developers transfer nanoparticle production from lab scale to liter-scale GMP output.

3 investors

Uncommon Bio has sold its cultivated meat platform to Vow and is now focusing on SymphoRNA, leveraging its nucleic acid delivery technology.

3 investors

Undermind provides AI-powered research discovery tools that help R&D teams find relevant scientific papers and research quickly. The platform serves biotech and pharmaceutical companies conducting drug discovery and development work.

3 investors

Unicorn Biotechnologies builds general-purpose cell culture robots that automate and standardize cell culture workflows, aimed at helping teams scale processes from R&D through pilot and commercial manufacturing. It serves biotech and regenerative medicine researchers working on cell-based products.

3 investors

uniQure is a biotech company developing gene therapies for serious genetic diseases. The company's pipeline includes investigational treatments for conditions such as Huntington's disease, epilepsy, and Fabry disease.

3 investors

Curebase offers an AI-powered eClinical software platform that supports clinical trials from study startup through database lock, covering study launch, data capture, and participant engagement. It serves clinical research organizations ranging from small biotechs to global CROs.

3 investors

UniteLabs provides a lab automation platform that lets biotech and pharma teams define and run laboratory workflows as Python code, integrating 175+ devices through a single cloud API. Its "Lab As Code" approach offers version control, bidirectional device connectivity, and integration with LIMS/ELN tools such as Benchling for R&D labs.

3 investors

UroGen is a biotech company developing treatments for urothelial and specialty cancers using a proprietary sustained-release hydrogel platform technology. The company commercializes approved therapies for bladder and upper tract cancers, with additional candidates in development.

3 investors

Terrestrial develops the Tacterra microarray patch platform, a dissolvable skin-patch technology for delivering therapies including GLP-1 without injection. The platform targets patients seeking more convenient, pain-free administration of next-generation therapeutics.

3 investors

Vanqua Bio is a biotechnology company developing molecules intended to become medicines for neurodegenerative disorders, including Parkinson's disease, Alzheimer's disease, and related neurological conditions. It serves patients with these diseases through its drug discovery and development work.

3 investors

VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings. The company focuses on advancing coagulation therapy for patients taking this class of blood thinners.

3 investors

VedaBio develops a molecular detection platform using CRISPR technology that enables rapid, accurate detection of multiple biological targets without the need for amplification. The platform serves research, diagnostics, and industrial applications across multiple markets.

3 investors

Velsera provides integrated software and expert services that turn complex biomedical and genomic data into usable insights for precision medicine, drug discovery, diagnostics development, and genetic testing. It serves organizations in the life sciences and healthcare sectors working on discovery, diagnostics, and regulatory navigation.

3 investors

3 investors

Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies. It serves medical spas, dermatologists, plastic surgeons, and hair transplant physicians across more than 60 countries.

3 investors

Veranex provides multi-disciplinary services to medical device and healthcare companies, supporting them from concept through commercialization of medical innovations. It positions itself as a partner to healthcare organizations across the medical product development process.

3 investors